Physician profile
Thomas E Odmark
NPI 1427005081
$2,873.50
in general payments reported to CMS, 2019-2025
27 companies · $264 in 2025
The $264 reported for 2025 was less than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,315 · 2020: $350 · 2021: $268 · 2022: $416 · 2023: $48.60 · 2024: $210 · 2025: $264.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $523.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $523.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Wright Medical Technology, INC. | $1,164.91 | 2019-2020 | |
| Stryker Corporation | $375.07 | 2019-2024 | Actishield, Infinity Adaptis, Prostep Mica |
| Medshape, INC. | $141.18 | 2025 | |
| Smith+Nephew, INC. | $137.70 | 2021-2025 | Grafix Pl |
| Mvp Orthopedics INC | $102.64 | 2021-2022 | |
| Electronic Waveform Lab, INC. | $98.87 | 2019-2022 | |
| Orthofix Medical, INC. | $82.10 | 2019-2021 | |
| Integra Lifesciences Corporation | $81.22 | 2019-2020 | |
| Bioventus LLC | $76.92 | 2019-2022 | |
| Acumed LLC | $74.84 | 2022 | |
| Organogenesis INC. | $72.55 | 2020 | |
| Heron Therapeutics, INC. | $64.86 | 2021-2022 | |
| Globus Medical, INC. | $45.72 | 2022 | |
| Coastal Medical Technologies LLC | $43.94 | 2024 | |
| Triad Life Sciences INC. | $38.45 | 2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $38.22 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Graftguide |
| Treace Medical Concepts, INC. | $35.56 | 2022-2025 | |
| Paragon 28, INC. | $26.20 | 2020-2025 | Trauma |
| Depuy Synthes Sales INC. | $25.00 | 2025 | Motoband |
| Axogen | $24.14 | 2021 | |
| Amgen INC. | $20.74 | 2019 | |
| Horizon Therapeutics Plc | $20.06 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $19.72 | 2022 | |
| Si-Bone, INC. | $16.52 | 2023 | |
| Omeza LLC | $16.21 | 2024 | |
| Arteriocyte Medical Systems, INC. | $15.63 | 2025 | Magellan |
| Arthrosurface Incorporated | $14.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Odmark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.